Three more questions you should pursue based on the debate over the SorryWorks! program, which protects doctors who apologize for medical errors that harm patients.
Unnecessary angioplasties, friendlier relations between insurers and care providers, hospitals that cater to the patient rather than focusing purely on the disease, and more from our Daily Briefing.
If a couple in good health with plenty of resources finds it this challenging to apply for health insurance policies, are lawmakers wise to propose replacing Medicare with vouchers?
Solana discusses his new job at the Medicare NewsGroup and why journalists shouldn't be afraid to chance something new.
Going into the second day of oral arguments before the Supreme Court regarding the constitutionality of the reform law, a new round of polling suggests that antipathy toward that buzzphrase — "individual mandate" — comes from a slim majority of the public.
Kern County, with similar geography and population to Fresno, decided to enter the new health insurance program called Bridge to Reform. On the way, Kern has stumbled upon many challenges, but for some patients, the program has changed their lives.
For the past twenty years, Shepherd's Clinic in Baltimore has provided comprehensive health care to the uninsured -- without any government funding. Since the recession began in 2008, more and more people are finding themselves walking through the clinic's doors for the first time.
The controversy over revisions to psychiatry's bible, the DSM, isn't just about autism. Guest blogger Mary Schweitzer throws chronic fatigue syndrome into the mix.
An opinion piece, borne of personal experience and a decade of mental health reporting, arguing in favor of many proposed changes to the DSM-5 that would allow early intervention for common mental disorders.
Recent studies have found statistical links between pesticide use and an outbreak of Parkinson's disease in California farm towns. Researchers even know which chemicals are the likely culprits. What's the government doing about it? Not much.
